Both a low-risk and an increased-risk sample report: clinical summary, variant interpretation, management recommendations, and family implications. Enter your details to view.
Preventative Screening
Around half your patients will get a different screening plan once you know their genetics.
Eugene's Preventative tests identify inherited risk for cancer, heart disease, and chronic conditions in asymptomatic patients, and return a personalised screening plan for every patient, whether or not a variant is found. Medicare-funded screening unlocks for those at increased risk.
The three tests
Choose the right test for the patient.
All Eugene Preventative tests include kit, prepaid shipping, lab analysis, clinical summary, and a one-on-one genetic counselling consult.
Most comprehensive
Preventative Health Test
- 184+ genes screened
- 65+ cancer, 85+ cardiac genes
- 25+ other genes, including diabetes, kidney & anaesthesia-reaction risk
- Best for a broad preventative screen across cancer, cardiac & metabolic risk
Proactive Cancer Risk Test
- 69+ genes screened
- Breast, ovarian, colorectal, prostate, pancreatic, melanoma
- Best for personal or family cancer history, even without a clear-cut pattern
Proactive Heart Health Test
- 88+ genes screened
- Cardiomyopathy, aortopathy, arrhythmia, familial hypercholesterolemia
- Best for cardiac family history or elevated cholesterol
Every patient comes back with a screening plan.
Eugene returns a personalised screening plan for every patient, integrating personal history, family history, and genetic results, whether a variant is found or not.
100%
Every patient
Every patient gets a clinical baseline including a genetic test, personal and family history reviewed by a genetic counsellor, and baseline screening recommendations.
~50%
Half of patients
Screening guidelines meaningfully adjusted based on family history and genetic test review.
~15%
One in seven
A genetic variant that influences their health is identified. A counsellor walks the patient through what it means and what's next.
6–8%
High impact
Pathogenic or likely pathogenic finding with a full management plan, specialist referrals, cascade testing for family, and specific surveillance protocols unlocked.
Explore the genes we screen
Gene list
Cancer Risk
genes
Heart Health
genes
Preventative Health
genes
These charts show the distribution of genes across health impact categories in our cancer, cardiac, and comprehensive preventative panels. The chart widths are proportional to each panel’s total genes.
This categorisation is based on the primary health impacts of each gene. Some genes influence multiple systems, but each is grouped by its single most clinically relevant impact.
Health Impact Categories
The Eugene platform
Sequence once. Build on it over time.
Eugene patients are sequenced once. As panels expand and new analyses become available, patients can come back to expand their results, without re-sequencing or re-collecting a sample.
The clinical relationship doesn't end at the result. Your patient stays in our care, and the genomic foundation keeps working for them.
Five steps. Four to six weeks.
From referral to clinical summary letter, Eugene handles everything between.
1
Refer the patient
3-minute referral.
2
At-home saliva sample
Prepaid envelope.
3
Accredited lab analysis
CLIA, CAP labs.
4
Genetic counsellor consult
One-on-one telehealth.
5
Clinical summary to you
Action-ready letter.
6 to 8% of asymptomatic patients screened return an actionable finding.
A patient in her late 30s, no personal or family history of cardiac disease. Preventative genomic screening identified a pathogenic SMAD9 variant associated with pulmonary arterial hypertension. She and her children were referred for cardiological surveillance and are now under active monitoring: a management pathway that would not have been initiated without screening.
For clinicians
I'm not a geneticist. What if a patient asks me a hard question?
I'm not a geneticist. What if a patient asks me a hard question?
You don't have to be. Eugene's genetic counsellor explains every result to the patient one-on-one, and you can call our clinical team for case discussion at any time.
What do I do with a low-risk result?
What do I do with a low-risk result?
Every Eugene patient, including low-risk results, comes back with personalised screening recommendations integrating personal history, family history, and the fact that genetics has ruled out an inherited component. Population-level screening is tailored to the patient and explained, so the result is still useful in your care plan.
I'm too busy to add a new workflow.
I'm too busy to add a new workflow.
Ordering takes 3 minutes. Eugene handles the rest: kit dispatch, patient onboarding, lab work, results, counselling. The only touchpoint after the order is the clinical summary letter.
What if we find something? What support will the patient get?
What if we find something? What support will the patient get?
Every increased-risk result triggers a one-on-one Eugene counsellor consult plus a clinical summary letter for your records. We coordinate specialist referrals and stay available for follow-up case discussion.
How is this different from MyDNA, 23andMe, or nutrigenomics?
How is this different from MyDNA, 23andMe, or nutrigenomics?
Eugene is clinical-grade germline screening of disease-risk genes, reviewed by certified genetic counsellors, not lifestyle or ancestry inference. 23andMe doesn't offer health testing in Australia; nutrigenomics looks at gene-diet interactions, not disease risk.
Will my patient feel anxious about the result?
Will my patient feel anxious about the result?
Eugene's pre-test consent and post-result counselling are built around supporting patients through whatever's found. Patient NPS sits above 75, including patients who received increased-risk results.
See what your patients receive.
